Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
cdc.gov/cancer/obesity/index.htm
Current human evidence from large-scale studies has not established a clear or direct link between GLP-1 medications and thyroid cancer in humans
However, in our practice, both medications have been successful in helping patients with type 2 diabetes manage their blood sugar and achieve weight loss
(Graphic: Business Wire) Providing access to safe, affordable weight loss solutions is more critical than ever yet many Americans do not have consistent access to these life-changing treatments
These effects are seen even outside of diabetes control.[ref] Decreased colon cancer mortality: A 5-year mortality study in colon cancer patients showed that GLP-1 RA use decreased mortality risk by 60% in obese patients.[ref] Decreased risk of substance abuse: A large 2026 study using data from the VA showed that GLP-1 RA drugs reduce the risk of developing a substance addiction (drugs, alcohol)
Does TRICARE cover Wegovy
